CY1123695T1 - Φαρμακευτικη συνθεση με αντιφλεγμονωδεις παραγοντες και διαδικασια παρασκευης - Google Patents

Φαρμακευτικη συνθεση με αντιφλεγμονωδεις παραγοντες και διαδικασια παρασκευης

Info

Publication number
CY1123695T1
CY1123695T1 CY20201101091T CY201101091T CY1123695T1 CY 1123695 T1 CY1123695 T1 CY 1123695T1 CY 20201101091 T CY20201101091 T CY 20201101091T CY 201101091 T CY201101091 T CY 201101091T CY 1123695 T1 CY1123695 T1 CY 1123695T1
Authority
CY
Cyprus
Prior art keywords
release
pharmaceutically acceptable
preparation
acceptable salts
pharmaceutical composition
Prior art date
Application number
CY20201101091T
Other languages
English (en)
Inventor
Federico AMEZCUA AMEZCUA
Amador COVARRUBIAS PINEDO
Original Assignee
Laboratorio Raam De Sahuayo, S.A. De C.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorio Raam De Sahuayo, S.A. De C.V. filed Critical Laboratorio Raam De Sahuayo, S.A. De C.V.
Publication of CY1123695T1 publication Critical patent/CY1123695T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

Η παρούσα εφεύρεση αφορά σε φαρμακευτικές συνθέσεις που χαρακτηρίζονται από το ότι περιλαμβάνουν ένα τριφασικό σύστημα απελευθέρωσης, το οποίο μπορεί να είναι καθυστερημένη απελευθέρωση και/ή παρατεταμένη απελευθέρωση και/ή τροποποιημένη απελευθέρωση και/ή άμεση απελευθέρωση, τουλάχιστον τριών στρωμάτων για το σχηματισμό τουλάχιστον μιας μονάδας δοσολογίας, όπου κάθε στρώμα περιλαμβάνει σαν δραστικά φαρμακευτικά συστατικά τουλάχιστον ένα κορτικοστεροειδή παράγοντα του τύπου βηταμεθαζόνης και/ή τα φαρμακευτικά αποδεκτά άλατα του, τουλάχιστον έναν μη στεροειδή αντιφλεγμονώδη παράγοντα του τύπου ασεκλοφενάκης και/ή φαρμακευτικά αποδεκτά άλατα του, και τουλάχιστον ένα φαρμακευτικά αποδεκτό έκδοχο. Επίσης περιγράφεται η νέα διαδικασία παρασκευής. Το αναφερόμενο τριφασικό σύστημα απελευθέρωσης δημιουργεί μία ενισχυμένη επίδραση θεραπείας για την αντιμετώπιση φλεγμονής και σωματικού πόνου.
CY20201101091T 2013-08-02 2020-11-17 Φαρμακευτικη συνθεση με αντιφλεγμονωδεις παραγοντες και διαδικασια παρασκευης CY1123695T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MX2013008992A MX348595B (es) 2013-08-02 2013-08-02 Composicion farmaceutica con agentes antiinflamatorios y proceso de produccion.
PCT/MX2014/000117 WO2015016698A1 (es) 2013-08-02 2014-07-24 Composición farmacéutica con agentes antiinflamatorios y proceso de producción

Publications (1)

Publication Number Publication Date
CY1123695T1 true CY1123695T1 (el) 2022-03-24

Family

ID=50935217

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20201101091T CY1123695T1 (el) 2013-08-02 2020-11-17 Φαρμακευτικη συνθεση με αντιφλεγμονωδεις παραγοντες και διαδικασια παρασκευης

Country Status (7)

Country Link
US (1) US20160243040A1 (el)
EP (1) EP3028706B1 (el)
CA (1) CA2946158C (el)
CY (1) CY1123695T1 (el)
ES (1) ES2832300T3 (el)
MX (1) MX348595B (el)
WO (1) WO2015016698A1 (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3108680A1 (en) * 2018-08-13 2020-02-20 AMEZCUA AMEZCUA, Federico Sinergic pharmaceutical composition of aceclofenac and betamethasone for the treatment of pain in localized forms of rheumatic conditions
MX2018013893A (es) * 2018-11-12 2019-05-13 Productos Maver S A De C V Composicion topica estable.
MX2019000312A (es) * 2019-01-08 2019-10-09 Federico Amezcua Amezcua Composicion farmaceutica sinergica de aceclofenaco y betametasona para el tratamiento del dolor de afecciones reumaticas o dolor postquirurgico.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB874586A (en) * 1957-10-28 1961-08-10 Upjohn Co Improvements in or relating to therapeutic compositions and the manufacture thereof
DE19849737A1 (de) * 1998-10-28 2000-05-04 Falk Pharma Gmbh Kombinationsmittel zur Behandlung entzündlicher Darmerkrankungen
US6423697B1 (en) * 1999-01-14 2002-07-23 Mark Friedman Intraoral topical anti-inflammatory treatment for relief of migraine, tension-type headache, post-traumatic headache, facial pain, and cervical-muscle spasm
CA2446904A1 (en) 2001-05-24 2003-04-03 Alexza Molecular Delivery Corporation Delivery of drug esters through an inhalation route
KR20030041577A (ko) 2001-11-20 2003-05-27 디디에스텍주식회사 난용성 약물과 치환된 시클로덱스트린을 함유하는고체분산체 및 이를 함유하는 약제학적 조성물
JP2007513165A (ja) 2003-12-02 2007-05-24 スリーエム イノベイティブ プロパティズ カンパニー Ｉｒｍ化合物を含む併用薬および治療方法
SE0401031D0 (sv) * 2004-04-22 2004-04-22 Duocort Ab A new glucocorticoid replacement therapy
EP2486942B1 (en) 2004-11-24 2018-10-10 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
WO2007072503A2 (en) 2005-12-21 2007-06-28 Panacea Biotec Ltd. Combinations for managing inflammation and associated disorders
KR101050076B1 (ko) * 2009-02-04 2011-07-19 한국유나이티드제약 주식회사 제어 방출성 아세클로페낙을 함유하는 경구 제제의 조성물 및 그의 제조방법
WO2010138441A1 (en) * 2009-05-28 2010-12-02 Aptapharma, Inc. Multilayer oral tablets containing a non-steroidal anti-inflammatory drug and/or acetaminophen
KR101234254B1 (ko) * 2010-06-01 2013-02-18 한국유나이티드제약 주식회사 1일 1회 투여로 최적의 약리학적 임상 효과를 제공하는 아세클로페낙 서방성 제제

Also Published As

Publication number Publication date
ES2832300T3 (es) 2021-06-10
US20160243040A1 (en) 2016-08-25
CA2946158C (en) 2022-01-18
CA2946158A1 (en) 2015-02-05
EP3028706B1 (en) 2020-08-19
WO2015016698A1 (es) 2015-02-05
MX348595B (es) 2017-06-21
EP3028706A1 (en) 2016-06-08
MX2013008992A (es) 2014-03-27
EP3028706A4 (en) 2017-04-26

Similar Documents

Publication Publication Date Title
CY1122730T1 (el) 1,2,4-τριαζολες ως διαμορφωτες πυρηνικης μεταφορας και χρησεις αυτων
CY1123695T1 (el) Φαρμακευτικη συνθεση με αντιφλεγμονωδεις παραγοντες και διαδικασια παρασκευης
CY1123476T1 (el) Τροποποιητες πυρηνικης μεταφορας και χρησεις αυτων
EA201690223A1 (ru) Ингибиторы фактора в комплемента на основе производных пиперидинилиндола и их применение
CY1119490T1 (el) Παραγωγα πυραζολοπυρρολιδινης και η χρηση τους στην θεραπεια νοσηματων
PE20151778A1 (es) Formulacion combinada de dos compuestos antivirales
CY1122113T1 (el) Φαρμακευτικες συνθεσεις για τη θεραπεια του ελικοβακτηριδιου του πυλωρου
BR112015018087A8 (pt) composto, composição farmacêutica e uso
BR112016000561B8 (pt) Compostos terapeuticamente ativos, uso dos mesmos, composição farmacêutica e uso da mesma
EA201592256A1 (ru) Производные имидазопирролидинона и их применение при лечении заболеваний
CR20140508A (es) Moduladores de la ruta del complemento y usos de los mismos
EA201491479A1 (ru) Производные лупановых тритерпеноидов и их фармацевтическое применение
CL2020000747A1 (es) Formulaciones de niraparib.
BR112015030315A2 (pt) derivado de 4-alquinilimidazol e medicamento compreendendo o mesmo como ingrediente ativo
CY1121089T1 (el) Χρηση των παραγωγων της βενζιμιδαζολης-προλινης
EA201592255A1 (ru) Производные пиразолопирролидин-4-она в качестве ингибиторов вет и их применение при лечении заболевания
CO6710926A2 (es) Compuestos de n-heteroarilo
DOP2016000007A (es) Pirazolpiridinas sustituidas
BR112015029894A2 (pt) forma de dosagem farmacêutica sólida
CL2015002466A1 (es) Formulaciones de compuestos orgánicos
BR112016000092A2 (pt) nanopartículas lipídicas para a cicatrização de feridas
BR112014031706A8 (pt) Composições farmacêuticas orais, e composição farmacêutica oral compreendendo itraconazol
BR112015018200A2 (pt) composição mastigável para administração oral e processo para preparar a mesma
AR094224A1 (es) Composicion farmaceutica en forma de una suspension oral
BR112014030288A8 (pt) composição farmacêutica, uso da mesma, e, uso de metanossulfonilacetonitrila